Maitri Enterprises Ltd
Incorporated in 1991, Maitri Enterprises Ltd is engaged in the business of Pharmaceutical products
- Market Cap ₹ 11.5 Cr.
- Current Price ₹ 26.2
- High / Low ₹ 41.5 / 19.0
- Stock P/E 25.0
- Book Value ₹ 13.1
- Dividend Yield 0.00 %
- ROCE 7.76 %
- ROE 6.63 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
- Debtor days have improved from 87.5 to 68.6 days.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 5.92% over last 3 years.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0.00 | 1.08 | 0.03 | 0.55 | 0.32 | 0.64 | 0.69 | 6.16 | 6.66 | 4.54 | 12.58 | 9.90 | 15.91 | |
0.15 | 1.09 | 0.20 | 0.63 | 0.41 | 0.71 | 0.73 | 6.17 | 6.67 | 4.45 | 12.17 | 9.31 | 15.19 | |
Operating Profit | -0.15 | -0.01 | -0.17 | -0.08 | -0.09 | -0.07 | -0.04 | -0.01 | -0.01 | 0.09 | 0.41 | 0.59 | 0.72 |
OPM % | -0.93% | -566.67% | -14.55% | -28.12% | -10.94% | -5.80% | -0.16% | -0.15% | 1.98% | 3.26% | 5.96% | 4.53% | |
-1.29 | 0.09 | 0.06 | 0.11 | 0.11 | 0.10 | 0.10 | 0.08 | 0.27 | 0.08 | 0.03 | 0.03 | 0.19 | |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.01 | 0.02 | 0.07 | 0.09 | 0.13 |
Depreciation | 0.00 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.03 | 0.04 | 0.05 | 0.07 | 0.06 | 0.05 |
Profit before tax | -1.44 | 0.06 | -0.13 | 0.01 | 0.00 | 0.02 | 0.04 | 0.02 | 0.21 | 0.10 | 0.30 | 0.47 | 0.73 |
Tax % | 0.00% | 16.67% | 0.00% | 0.00% | 0.00% | 25.00% | 50.00% | 23.81% | 40.00% | 26.67% | 29.79% | ||
-1.44 | 0.05 | -0.13 | 0.01 | 0.00 | 0.02 | 0.02 | 0.01 | 0.16 | 0.07 | 0.22 | 0.34 | 0.46 | |
EPS in Rs | -3.03 | 0.11 | -0.27 | 0.02 | 0.00 | 0.11 | 0.11 | 0.05 | 0.84 | 0.37 | 0.50 | 0.77 | 1.06 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 25% |
5 Years: | 70% |
3 Years: | 14% |
TTM: | 63% |
Compounded Profit Growth | |
---|---|
10 Years: | 21% |
5 Years: | 76% |
3 Years: | 29% |
TTM: | 119% |
Stock Price CAGR | |
---|---|
10 Years: | 17% |
5 Years: | 26% |
3 Years: | 64% |
1 Year: | 14% |
Return on Equity | |
---|---|
10 Years: | 3% |
5 Years: | 6% |
3 Years: | 6% |
Last Year: | 7% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4.75 | 4.75 | 4.75 | 4.75 | 1.90 | 1.90 | 1.90 | 1.90 | 1.90 | 1.90 | 4.40 | 4.40 |
Reserves | -2.73 | -2.68 | -2.81 | -2.80 | -0.14 | -0.13 | -0.10 | -0.09 | 0.07 | 0.14 | 0.56 | 0.90 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.40 | 1.77 | 2.41 | |
0.13 | 0.06 | 0.09 | 0.18 | 0.11 | 0.40 | 0.26 | 3.28 | 2.59 | 3.96 | 4.91 | 5.76 | |
Total Liabilities | 2.15 | 2.13 | 2.03 | 2.13 | 1.87 | 2.17 | 2.06 | 5.09 | 4.67 | 6.40 | 11.64 | 13.47 |
0.06 | 0.12 | 0.11 | 0.09 | 0.08 | 0.06 | 0.06 | 0.13 | 0.10 | 0.22 | 0.18 | 0.15 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.37 | 3.37 |
2.09 | 2.01 | 1.92 | 2.04 | 1.79 | 2.11 | 2.00 | 4.96 | 4.57 | 6.18 | 8.09 | 9.95 | |
Total Assets | 2.15 | 2.13 | 2.03 | 2.13 | 1.87 | 2.17 | 2.06 | 5.09 | 4.67 | 6.40 | 11.64 | 13.47 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.17 | 0.09 | -0.11 | 0.00 | 0.02 | -0.22 | 0.00 | 0.17 | 0.64 | -0.17 | -0.62 | -0.20 | |
-0.06 | -0.07 | -0.01 | 0.00 | 0.00 | 0.00 | -0.01 | -0.08 | -0.62 | -0.06 | -3.39 | -0.26 | |
-0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.27 | 3.99 | 0.55 | |
Net Cash Flow | 0.10 | 0.02 | -0.12 | 0.00 | 0.02 | -0.22 | -0.02 | 0.10 | 0.01 | 0.04 | -0.01 | 0.09 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 196.02 | 3,163.33 | 106.18 | 433.44 | 250.94 | 333.26 | 81.77 | 60.29 | 126.22 | 67.60 | 68.58 | |
Inventory Days | 249.27 | 7,178.33 | 419.75 | 580.68 | 423.07 | 304.17 | 123.56 | 132.35 | 318.36 | 140.85 | 273.63 | |
Days Payable | 22.26 | 851.67 | 155.12 | 182.50 | 331.82 | 174.90 | 203.62 | 155.50 | 397.44 | 145.93 | 242.72 | |
Cash Conversion Cycle | 423.03 | 9,490.00 | 370.81 | 831.62 | 342.19 | 462.53 | 1.71 | 37.14 | 47.14 | 62.52 | 99.49 | |
Working Capital Days | 554.26 | 19,831.67 | 1,101.64 | 1,882.03 | 941.02 | 893.99 | 67.55 | 44.39 | 79.59 | 56.58 | 96.60 | |
ROCE % | -2.19% | 2.93% | -6.48% | 0.51% | 0.00% | 1.13% | 2.80% | 2.22% | 11.31% | 5.31% | 8.07% | 7.76% |
Documents
Announcements
- Closure of Trading Window 1d
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
16 Feb - Newspaper Advertisement for Un-audited Standalone & Consolidated Financial Results of the Company for the quarter & Nine months ended on 31.12.2023
- Results For 31.12.2023 14 Feb
- Board Meeting Outcome for Outcome Of Board Meeting Of The Board 14 Feb
- Board Meeting Intimation for Notice Of Board Meeting 7 Feb
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Business Overview:[1]
a) Trading of Pharmaceutical & Medical Goods
b) Manufacturing of metal furniture
c) Trading of building materials